Novel Polymer-Based Coil Now Available from Embolization

June 8, 2026 – Embolization, Inc. will present its novel embolization coil, using proprietary shape-memory biocompatible polymers to treat peripheral vasculature at the Vascular Annual Meeting, in Boston, Massachusetts.

Embolization will be highlighting its NED coil. Intended for arterial and venous embolization in peripheral vasculature, the novel, polymer-based device minimizes artifacts in CT and MRI imaging that occur with traditional metal devices, according to Jim Kasic, Embolization's CEO.

The NED, which has obtained FDA 501(k) clearance, is the only polymer-based coil on the market; all others are metal-based. The coils, Kasic says, remain radiopaque under fluoroscopy even though the CT/MRI imaging artifact is minimal.

Kasic says that initial results show shorter occlusion times and tighter coil packs, which can result in fewer devices per procedure, lower recanalization rates and lower manufacturing costs. “The NED coil does everything a traditional metal coil does, but with a novel, radiopaque polymer.”

NED is demonstrating success in its limited-market release, with use cases topping 70 coils in 11 cases. In all cases, across four institutions and physicians, the NED has shown consistent performance  in venous and arterial applications.

“The opportunity to talk with experts at VAM, the premier source of education for vascular health professionals, is an opportunity to share what I believe represents the next generation in embolic coils,” says Kasic.

Embolization, Inc., based in Boulder, Colorado, specializes in the development of minimally invasive medical devices for peripheral vascular and neurovascular uses.